| Acute graft-vs-host disease: pathobiology and management H Goker, IC Haznedaroglu, NJ Chao Experimental hematology 29 (3), 259-277, 2001 | 504 | 2001 |
| Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper® H Goker, IC Haznedaroglu, S Ercetin, S Kirazli, U Akman, Y Ozturk, ... Journal of International Medical Research 36 (1), 163-170, 2008 | 432 | 2008 |
| Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ... The Lancet 393 (10168), 253-264, 2019 | 261 | 2019 |
| The effects of blood group types on the risk of COVID-19 infection and its clinical outcome H Göker, EA Karakulak, H Demiroğlu, ÇMA Ceylan, Y Büyükaşik, ... Turkish journal of medical sciences 50 (4), 679-683, 2020 | 233 | 2020 |
| Synthesis and potent antibacterial activity against MRSA of some novel 1, 2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines H Göker, S Özden, S Yıldız, DW Boykin European journal of medicinal chemistry 40 (10), 1062-1069, 2005 | 198 | 2005 |
| Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma … M Beksac, R Haznedar, T Firatli‐Tuglular, H Ozdogu, I Aydogdu, N Konuk, ... European journal of haematology 86 (1), 16-22, 2011 | 178 | 2011 |
| Evaluation of hemostatic effects of Ankaferd as an alternative medicine Y Beyazit, M Kurt, M Kekilli, H Goker, IC Haznedaroglu Altern Med Rev 15 (4), 329-336, 2010 | 173 | 2010 |
| In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin HS Cipil, A Kosar, A Kaya, B Uz, IC Haznedaroglu, H Goker, O Ozdemir, ... Clinical and Applied Thrombosis/Hemostasis 15 (3), 270-276, 2009 | 148 | 2009 |
| Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model H Bilgili, A Kosar, M Kurt, IK Onal, H Goker, O Captug, A Shorbagi, ... Medical Principles and Practice 18 (3), 165-169, 2009 | 129 | 2009 |
| Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical … F Baron, M Labopin, D Blaise, L Lopez-Corral, S Vigouroux, C Craddock, ... Bone marrow transplantation 49 (3), 389-396, 2014 | 113 | 2014 |
| Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case … NM Nuamah, H Goker, YA Kilic, H Dagmoura, A Cakmak Haematologica 91 (5_Suppl), ECR08-ECR08, 2006 | 112 | 2006 |
| Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper BZ Haznedaroglu, IC Haznedaroglu, SL Walker, H Bilgili, H Goker, ... Clinical and Applied Thrombosis/Hemostasis 16 (4), 446-453, 2010 | 104 | 2010 |
| The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model A Kosar, HS Cipil, A Kaya, B Uz, IC Haznedaroglu, H Goker, O Ozdemir, ... Blood coagulation & fibrinolysis 20 (3), 185-190, 2009 | 99 | 2009 |
| Synthesis and antiparasitic and antifungal evaluation of 2′-arylsubstituted-1H, 1′ H-[2, 5′] bisbenzimidazolyl-5-carboxamidines M Alp, H Göker, R Brun, S Yıldız European journal of medicinal chemistry 44 (5), 2002-2008, 2009 | 84 | 2009 |
| In vitro anti-bacterial activities of Ankaferd medicinal plant extract N Akkoc, M Akcelik, IC Haznedaroglu, H Goker, M Turgut, S Aksu, ... Turkiye Klinikleri Tip Bilimleri Dergisi 29 (2), 410-415, 2009 | 84 | 2009 |
| Safety and efficacy of Ankaferd Blood Stopper in dental surgery S Ercetin, IC Haznedaroglu, K Mevlut, A AKTAS, H GOKER, O OZDEMIR, ... International Journal of Hematology and Oncology 33 (1), 001-005, 2010 | 81 | 2010 |
| Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study M Mohty, E Terpos, MV Mateos, M Cavo, S Lejniece, M Beksac, ... Clinical Lymphoma Myeloma and Leukemia 18 (10), e401-e419, 2018 | 79 | 2018 |
| Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model H Bilgili, O Captug, A Kosar, M Kurt, M Kekilli, A Shorbagi, OK Kurt, ... Clinical and Applied Thrombosis/Hemostasis 16 (5), 533-536, 2010 | 73 | 2010 |
| Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. Y Beyazit, S Aksu, IC Haznedaroglu, M Kekilli, M Misirlioglu, S Tuncer, ... Journal of the National Medical Association 99 (1), 57, 2007 | 69 | 2007 |
| Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease Y Buyukasik, S Karakus, H Goker, IC Haznedaroglu, D Ozatli, N Sayinalp, ... Blood coagulation & fibrinolysis 13 (4), 349-353, 2002 | 66 | 2002 |
Ibrahim C. HaznedarogluHacettepe Medical School在 hacettepe.edu.tr 的电子邮件经过验证
